Real-world evidence on disparities on the initiation of Ticagrelor versus Prasugrel in patients with acute coronary syndrome

Background: Management of patients with non-ST-segment-elevation acute coronary syndrome (NSTE-ACS) is based on 2020 European Society of Cardiology guidelines, which recommend the preferential use of prasugrel over ticagrelor. Because the selection of the respective P2Y12 inhibitor has to consider l...

Full description

Saved in:
Bibliographic Details
Main Authors: Yildirim, Mustafa (Author) , Müller-Hennessen, Matthias (Author) , Milles, Barbara Ruth (Author) , Biener, Moritz (Author) , Hund, Hauke (Author) , Frey, Norbert (Author) , Giannitsis, Evangelos (Author) , Salbach, Christian (Author)
Format: Article (Journal)
Language:English
Published: August 15, 2023
In: Journal of the American Heart Association
Year: 2023, Volume: 12, Issue: 16, Pages: 1-10
ISSN:2047-9980
DOI:10.1161/JAHA.123.030879
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1161/JAHA.123.030879
Verlag, kostenfrei, Volltext: https://www.ahajournals.org/doi/10.1161/JAHA.123.030879
Get full text
Author Notes:Mustafa Yildirim, Matthias Mueller-Hennessen, Barbara Ruth Milles, Moritz Biener, Hauke Hund, Norbert Frey, Evangelos Giannitsis, Christian Salbach

MARC

LEADER 00000caa a2200000 c 4500
001 1860681808
003 DE-627
005 20240307052214.0
007 cr uuu---uuuuu
008 231004s2023 xx |||||o 00| ||eng c
024 7 |a 10.1161/JAHA.123.030879  |2 doi 
035 |a (DE-627)1860681808 
035 |a (DE-599)KXP1860681808 
035 |a (OCoLC)1425210949 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Yildirim, Mustafa  |d 1995-  |e VerfasserIn  |0 (DE-588)1304894592  |0 (DE-627)1860685455  |4 aut 
245 1 0 |a Real-world evidence on disparities on the initiation of Ticagrelor versus Prasugrel in patients with acute coronary syndrome  |c Mustafa Yildirim, Matthias Mueller-Hennessen, Barbara Ruth Milles, Moritz Biener, Hauke Hund, Norbert Frey, Evangelos Giannitsis, Christian Salbach 
264 1 |c August 15, 2023 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.10.2023 
520 |a Background: Management of patients with non-ST-segment-elevation acute coronary syndrome (NSTE-ACS) is based on 2020 European Society of Cardiology guidelines, which recommend the preferential use of prasugrel over ticagrelor. Because the selection of the respective P2Y12 inhibitor has to consider label restrictions, we sought to evaluate the proportion of patients qualifying for either ticagrelor or prasugrel and reasons for noneligibility in an unselected cohort of patients with acute coronary syndrome. Methods and Results In this retrospective observational study, patients with ST-segment-elevation myocardial infarction (STEMI) or NSTE-ACS presenting consecutively during a 24-month period were enrolled. The eligibility of patients for a dual antiplatelet therapy option was assessed retrospectively. A total of 1502 patients had confirmed acute coronary syndrome (287 STEMI and 1215 NSTE-ACS). Eligibility for ticagrelor and full-dose prasugrel differed significantly for STEMI and NSTE-ACS (93% versus 51%, P<0.0001 versus 80% versus 31%, P<0.0001). Eligibility remained significantly lower (STEMI 78% versus NSTE-ACS 52%) if low-dose prasugrel was considered. Patients eligible for full-dose prasugrel had lower ischemic risk per GRACE (Global Registry of Acute Coronary Events) score (109 points [90-129 points] versus 121 points [98-146 points], P<0.0001) and lower bleeding risk (14 points [13-15 points] versus 20 points [12-29 points], P<0.0001) per PRECISE-DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy) score. Conclusions In real life, eligibility for prasugrel in patients requiring dual antiplatelet therapy is considerably lower than for ticagrelor, even in a cohort with high rates of coronary angiography and percutaneous coronary interventions. The recommended use of prasugrel over ticagrelor in current acute coronary syndrome guidelines contrasts with our observations of a substantial disparity on the eligibility. This important aspect has not received appropriate attention yet. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT05774431. 
650 4 |a acute coronary syndrome 
650 4 |a eligibility 
650 4 |a humans 
650 4 |a label use 
650 4 |a myocardial infarction 
650 4 |a percutaneous coronary intervention 
650 4 |a platelet aggregation inhibitors 
650 4 |a prasugrel 
650 4 |a prasugrel hydrochloride 
650 4 |a purinergic P2Y receptor antagonists 
650 4 |a retrospective studies 
650 4 |a ST Elevation Myocardial Infarction 
650 4 |a ticagrelor 
650 4 |a Ticagrelor 
650 4 |a treatment outcome 
700 1 |a Müller-Hennessen, Matthias  |e VerfasserIn  |0 (DE-588)1058117955  |0 (DE-627)796417679  |0 (DE-576)414119061  |4 aut 
700 1 |a Milles, Barbara Ruth  |d 1995-  |e VerfasserIn  |0 (DE-588)1231944676  |0 (DE-627)1755614330  |4 aut 
700 1 |a Biener, Moritz  |d 1983-  |e VerfasserIn  |0 (DE-588)101853119X  |0 (DE-627)682858374  |0 (DE-576)355963876  |4 aut 
700 1 |a Hund, Hauke  |e VerfasserIn  |0 (DE-588)1144198267  |0 (DE-627)1004020198  |0 (DE-576)453613489  |4 aut 
700 1 |a Frey, Norbert  |e VerfasserIn  |0 (DE-588)141244976  |0 (DE-627)625824075  |0 (DE-576)322969514  |4 aut 
700 1 |a Giannitsis, Evangelos  |e VerfasserIn  |0 (DE-588)113336241  |0 (DE-627)577184091  |0 (DE-576)289759579  |4 aut 
700 1 |a Salbach, Christian  |e VerfasserIn  |0 (DE-588)1200157389  |0 (DE-627)168241230X  |4 aut 
773 0 8 |i Enthalten in  |a American Heart Association  |t Journal of the American Heart Association  |d New York, NY : Association, 2012  |g 12(2023), 16 vom: Aug., Artikel-ID e030879, Seite 1-10  |h Online-Ressource  |w (DE-627)688605427  |w (DE-600)2653953-6  |w (DE-576)361844719  |x 2047-9980  |7 nnas 
773 1 8 |g volume:12  |g year:2023  |g number:16  |g month:08  |g elocationid:e030879  |g pages:1-10  |g extent:10  |a Real-world evidence on disparities on the initiation of Ticagrelor versus Prasugrel in patients with acute coronary syndrome 
856 4 0 |u https://doi.org/10.1161/JAHA.123.030879  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.ahajournals.org/doi/10.1161/JAHA.123.030879  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20231004 
993 |a Article 
994 |a 2023 
998 |g 1200157389  |a Salbach, Christian  |m 1200157389:Salbach, Christian  |d 910000  |d 910100  |e 910000PS1200157389  |e 910100PS1200157389  |k 0/910000/  |k 1/910000/910100/  |p 8  |y j 
998 |g 113336241  |a Giannitsis, Evangelos  |m 113336241:Giannitsis, Evangelos  |d 910000  |d 910100  |d 50000  |e 910000PG113336241  |e 910100PG113336241  |e 50000PG113336241  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 141244976  |a Frey, Norbert  |m 141244976:Frey, Norbert  |d 910000  |d 910100  |e 910000PF141244976  |e 910100PF141244976  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1144198267  |a Hund, Hauke  |m 1144198267:Hund, Hauke  |d 910000  |d 910100  |e 910000PH1144198267  |e 910100PH1144198267  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 101853119X  |a Biener, Moritz  |m 101853119X:Biener, Moritz  |d 910000  |d 910100  |d 50000  |e 910000PB101853119X  |e 910100PB101853119X  |e 50000PB101853119X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
998 |g 1231944676  |a Milles, Barbara Ruth  |m 1231944676:Milles, Barbara Ruth  |d 910000  |d 910100  |e 910000PM1231944676  |e 910100PM1231944676  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1058117955  |a Müller-Hennessen, Matthias  |m 1058117955:Müller-Hennessen, Matthias  |d 50000  |e 50000PM1058117955  |k 0/50000/  |p 2 
998 |g 1304894592  |a Yildirim, Mustafa  |m 1304894592:Yildirim, Mustafa  |d 910000  |d 910100  |e 910000PY1304894592  |e 910100PY1304894592  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1860681808  |e 4380851559 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2047-9980"],"eki":["688605427"],"zdb":["2653953-6"]},"title":[{"title":"Journal of the American Heart Association","subtitle":"JAHA","title_sort":"Journal of the American Heart Association"}],"origin":[{"dateIssuedDisp":"2012-","publisher":"Association","publisherPlace":"New York, NY","dateIssuedKey":"2012"}],"recId":"688605427","disp":"American Heart AssociationJournal of the American Heart Association","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"aut","display":"American Heart Association"}],"titleAlt":[{"title":"Journal of the American Heart Association, Cardiovascular and Cerebrovascular Disease"},{"title":"JAHA"}],"part":{"extent":"10","pages":"1-10","issue":"16","text":"12(2023), 16 vom: Aug., Artikel-ID e030879, Seite 1-10","volume":"12","year":"2023"},"language":["eng"],"pubHistory":["1.2012 -"],"note":["Gesehen am 09.01.14"]}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"August 15, 2023"}],"title":[{"title_sort":"Real-world evidence on disparities on the initiation of Ticagrelor versus Prasugrel in patients with acute coronary syndrome","title":"Real-world evidence on disparities on the initiation of Ticagrelor versus Prasugrel in patients with acute coronary syndrome"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"id":{"doi":["10.1161/JAHA.123.030879"],"eki":["1860681808"]},"person":[{"role":"aut","family":"Yildirim","display":"Yildirim, Mustafa","given":"Mustafa"},{"family":"Müller-Hennessen","role":"aut","display":"Müller-Hennessen, Matthias","given":"Matthias"},{"role":"aut","family":"Milles","given":"Barbara Ruth","display":"Milles, Barbara Ruth"},{"family":"Biener","role":"aut","given":"Moritz","display":"Biener, Moritz"},{"given":"Hauke","display":"Hund, Hauke","role":"aut","family":"Hund"},{"given":"Norbert","display":"Frey, Norbert","family":"Frey","role":"aut"},{"given":"Evangelos","display":"Giannitsis, Evangelos","role":"aut","family":"Giannitsis"},{"given":"Christian","display":"Salbach, Christian","role":"aut","family":"Salbach"}],"recId":"1860681808","note":["Gesehen am 04.10.2023"],"name":{"displayForm":["Mustafa Yildirim, Matthias Mueller-Hennessen, Barbara Ruth Milles, Moritz Biener, Hauke Hund, Norbert Frey, Evangelos Giannitsis, Christian Salbach"]},"language":["eng"]} 
SRT |a YILDIRIMMUREALWORLDE1520